Skip to main content

The use of electronic consent (e-Consent) in randomised trials

About the Collection:

Whilst e-Consent was permitted from a regulatory and ethical perspective previously, its use has increased more recently, not least due to the Covid-19 pandemic and the need to move some clinical trial processes remotely. Whilst there may be benefits to implementing e-Consent, it is not without challenges and as more people engage in implementing e-Consent, Trials is keen to share trialists’ experiences, innovations, case studies and methodological research into this emerging area.

Submission Status: Closed |   Submission Deadline: Closed

This collection is no longer accepting submissions

  1. During the COVID-19 pandemic, in-person healthcare visits were reduced. Consequently, trial teams needed to consider implementing remote methods for conducting clinical trials, including e-Consent. Although so...

    Authors: E. J. Mitchell, D. Appelbe, A. Bravery, L. Culliford, H. Evans, A. J. Farrin, K. Gillies, K. Hood, S. B. Love, M. R. Sydes, P. R. Williamson and N. Wakefield
    Citation: Trials 2023 24:657